Howard Hughes Holdings is evolving from a pure land developer into a diversified holding company by adding an insurance business through Vantage's acquisition, expected to impact 2026 results. Despite trading about 29% below Pershing Square's $100 preferred entry price and near $71, the stock is valued below the analyst's $95–$115 fair value range, supported by strong core real estate performance. Insider buying near lows, especially by Vantage's Executive Chairman, signals confidence. The analyst maintains a bullish outlook but notes technical confirmation requires a weekly close above $74, with Q3 being the first full quarter including Vantage's operations.
Howard Hughes Holdings market context shows mixed performance in related sectors. For readers following real estate, here is Pluang's market snapshot as of Oct 05, 2026 17:01 WIB: Of 26 priced US real estate stocks, 11 rose and 6 fell. Notable movers include BEKE at USD 16.39 (-0.24%), ARR at USD 13.62 (+0.22%), and PLD at USD 128.67 (-0.19%).
Bank of America upgraded DraftKings stock to Buy from Neutral, citing reduced risks from prediction markets and a favorable risk-reward at current prices. DraftKings shares rose 5% following the upgrade, while competitors Flutter Entertainment and MG...
Vertiv has named Michael Resha as Executive Vice President of Manufacturing, Logistics, and Operational Excellence, succeeding Anders Karlborg who moves to a new role. Resha will lead global manufacturing and logistics efforts to scale operations and...
Cerrado Gold (CRDOF) has been upgraded to a Buy rating due to improved production at its Minera Don Nicolas (MDN) mine, which reached 15,415 gold equivalent ounces in Q2, supporting the annual target of 50,000 GEO. However, cost control remains a cha...
Rapid Dose Therapeutics announced it will issue common shares to settle $142,067.63 of accrued interest on its secured convertible notes by October 15, 2026. The notes, originally issued in 2023, bear 18% annual interest payable quarterly in shares a...
JP Morgan has put Unilever on positive watch and Haleon on negative watch ahead of the third-quarter earnings reports from European consumer staples companies. The broker also favors Givaudan, Heineken, and Danone, particularly in beer, ingredients, ...
